Get startedLog in
    Picture of Star Combo Pharma logo

    S66 — Star Combo Pharma Cashflow Statement

    0.000.00%
    au flag iconLast trade - 00:00
    Consumer CyclicalsSpeculativeMicro CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Star Combo Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

    R2021
    June 30th
    2022
    June 30th
    2023
    June 30th
    2024
    June 30th
    2025
    June 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSInterim Report
    Standards:
    AAS
    AAS
    AAS
    AAS    		—
    Status:FinalFinalFinalFinalFinal
    Changes in Working Capital0.4660.5410.1280.2610.429
    Other Operating Cash Flow
    Cash from Operating Activities0.3320.5341.88-0.31611.9
    Capital Expenditures-7.26-7.29-2.73-1.44-0.394
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items9.684.05-0.51.3-9.33
    Acquisition of Business
    Change in Net Investments
    Other Investing Cash Flow
    Cash from Investing Activities2.42-3.24-3.23-0.137-9.72
    Financing Cash Flow Items——-0.201-0.207-0.202
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-2.08-0.169-0.053-0.371-0.896
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.671-2.88-1.41-0.8241.43